Louise Faaborg
5PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 27, 2026
Bevacizumab and Tocotrienol in Recurrent Platinum-Resistant Ovarian Cancer, and the Role of HOXA9 as a Prognostic Biomarker.Elisabeth Emanuel Graae, Louise Faaborg, Rikke Fredslund Andersen
|Nov 15, 2023
Prognostic impact of early ctDNA dynamics during chemotherapy of metastatic cancer.Louise Faaborg, Rikke Fredslund Andersen, Sara Wc Wen
|Apr 12, 2022
Prognostic Impact of Circulating Methylated Homeobox A9 DNA in Patients Undergoing Treatment for Recurrent Ovarian Cancer.Louise Faaborg, Rikke Fredslund Andersen, Marianne Waldstrøm
|Feb 15, 2022
Differences in Administration of Methotrexate and Impact on Outcome in Low-Risk Gestational Trophoblastic Neoplasia.Emelie Wallin, Isa Niemann, Louise Faaborg
|Sep 13, 2021
HOXA9-methylated DNA as a diagnostic biomarker of ovarian malignancy.Louise Faaborg, Anders Jakobsen, Marianne Waldstrøm
Pageof 1
